Off-the-shelf cell therapy takes on aggressive blood cancers
Disease control
Recruiting now
This early-stage trial tests a new treatment called Azer-cel, a type of immune cell therapy made from donor cells, for adults with certain blood cancers that have come back or not responded to standard treatments. The goal is to see if it is safe and can shrink tumors or put the …
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC